Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00824707
What this trial is testing

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT06786429
What this trial is testing

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Who this might be right for
Hepatitis BHuman Papilloma VirusMental Health Issue+3 more
Eunice Dube 2,140
Testing effectiveness (Phase 2)Active Not RecruitingNCT03719131
What this trial is testing

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVStage III Melanoma+5 more
Emory University 15
Not applicableStudy completedNCT01653002
What this trial is testing

Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging

Who this might be right for
Lung Cancer With Mediastinal Lymph Node Involvement
University Hospital, Essen 200
Testing effectiveness (Phase 2)Ended earlyNCT01928030
What this trial is testing

Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer

Who this might be right for
LymphedemaMalignant Neoplasm
Stanford University 3
Not applicableStudy completedNCT04660331
What this trial is testing

Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study

Who this might be right for
Human Papillomavirus Infection
Fred Hutchinson Cancer Center 42
Early research (Phase 1)Ended earlyNCT05098405
What this trial is testing

First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Molecular Partners AG 46
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Post-approval studies (Phase 4)UnknownNCT05439083
What this trial is testing

Immunogenicity of 9-valent HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection
Talia Sainz Costa 120
Early research (Phase 1)Study completedNCT04855929
What this trial is testing

A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

Who this might be right for
Advanced Solid TumorAdult DiseaseLung Cancer
Anaveon AG 55
Large-scale testing (Phase 3)Looking for participantsNCT07071337
What this trial is testing

SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy

Who this might be right for
Metastatic Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430
Early research (Phase 1)Study completedNCT01221571
What this trial is testing

Assess AFM13 in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Affimed GmbH 28
Large-scale testing (Phase 3)Ended earlyNCT06038539
What this trial is testing

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Who this might be right for
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd 55
Early research (Phase 1)Study completedNCT05075564
What this trial is testing

ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
Elpiscience Biopharma, Ltd. 8
Not applicableStudy completedNCT00977639
What this trial is testing

Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies

Who this might be right for
Neoplasm Metastasis
Stanford University 2
Not applicableStudy completedNCT00866957
What this trial is testing

Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)

Who this might be right for
Liver Cancer
Northwestern University 180
Early research (Phase 1)Study completedNCT03309111
What this trial is testing

Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA 81
Large-scale testing (Phase 3)Active Not RecruitingNCT03734029
What this trial is testing

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

Who this might be right for
Breast Cancer
Daiichi Sankyo 557
Early research (Phase 1)Active Not RecruitingNCT05359445
What this trial is testing

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor

Who this might be right for
Refractory CancerRecurrent CancerSolid Tumor, Adult+1 more
Immatics Biotechnologies GmbH 95
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Next Page